Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017114 |
---|---|
Receipt number | R000019854 |
Scientific Title | Multicenter Phase 1b/2 Trial of Nintedanib with TAS-102 in Patients with Metastatic Colorectal Cancer (mCRC) who had the progression or intolerant to standard therapies. |
Date of disclosure of the study information | 2015/04/13 |
Last modified on | 2017/10/13 13:55:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/04/13 11:14:38 | ||
2 | Update | 2015/08/21 16:25:58 | Recruitment status Anticipated trial start date |
|
3 | Update | 2016/04/12 08:57:52 | Name of primary person or sponsor Organization |
|
4 | Update | 2016/10/03 09:48:49 | Recruitment status Last follow-up date |
|
5 | Update | 2016/10/13 09:10:03 | Publication of results Results |
|
6 | Update | 2017/04/13 13:16:05 | Organization Organization Division name Institute Institute Name of secondary funder(s) Name of secondary funder(s) Institutions |
|
7 | Update | 2017/10/13 13:55:44 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete |